These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Serum magnesium, mortality, and cardiovascular disease in chronic kidney disease and end-stage renal disease patients: a systematic review and meta-analysis. Xiong J; He T; Wang M; Nie L; Zhang Y; Wang Y; Huang Y; Feng B; Zhang J; Zhao J J Nephrol; 2019 Oct; 32(5):791-802. PubMed ID: 30888644 [TBL] [Abstract][Full Text] [Related]
8. The emerging role of magnesium in CKD. Sakaguchi Y Clin Exp Nephrol; 2022 May; 26(5):379-384. PubMed ID: 35076791 [TBL] [Abstract][Full Text] [Related]
9. [Vascular Calcification - Pathological Mechanism and Clinical Application - . Vascular calcification in chronic kidney disease-mineral and bone disorder (CKD-MBD)]. Omata M; Fukagawa M; Kakuta T Clin Calcium; 2015 May; 25(5):645-53. PubMed ID: 25926567 [TBL] [Abstract][Full Text] [Related]
12. Therapy for the altered mineral metabolism of chronic kidney disease: implications for vascular calcification. Saab G; Whaley-Connell AT; Khanna R; Sowers JR Ther Adv Cardiovasc Dis; 2007 Dec; 1(2):107-12. PubMed ID: 19124399 [TBL] [Abstract][Full Text] [Related]
13. Mineral metabolism and cardiovascular disease in CKD. Fujii H; Joki N Clin Exp Nephrol; 2017 Mar; 21(Suppl 1):53-63. PubMed ID: 28062938 [TBL] [Abstract][Full Text] [Related]
14. [Magnesium disorder and its clinical significance in chronic kidney disease]. Okuno S Clin Calcium; 2012 Aug; 22(8):1243-9. PubMed ID: 22846361 [TBL] [Abstract][Full Text] [Related]
15. Effects of Magnesium on the Phosphate Toxicity in Chronic Kidney Disease: Time for Intervention Studies. Sakaguchi Y; Hamano T; Isaka Y Nutrients; 2017 Feb; 9(2):. PubMed ID: 28178182 [TBL] [Abstract][Full Text] [Related]
16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
17. Pathophysiology and treatment of cardiovascular disease in pediatric chronic kidney disease. Khouzam N; Wesseling-Perry K Pediatr Nephrol; 2019 Jan; 34(1):1-10. PubMed ID: 28939921 [TBL] [Abstract][Full Text] [Related]
18. Bone Morphogenetic Proteins 2/4 Are Upregulated during the Early Development of Vascular Calcification in Chronic Kidney Disease. Wei X; Wu W; Li L; Lin J; Liu Q; Gan L; Ou S Biomed Res Int; 2018; 2018():8371604. PubMed ID: 29850574 [TBL] [Abstract][Full Text] [Related]
19. Magnesium in CKD: more than a calcification inhibitor? Floege J J Nephrol; 2015 Jun; 28(3):269-77. PubMed ID: 25227765 [TBL] [Abstract][Full Text] [Related]
20. Magnesium and outcomes in patients with chronic kidney disease: focus on vascular calcification, atherosclerosis and survival. Massy ZA; Drüeke TB Clin Kidney J; 2012 Feb; 5(Suppl 1):i52-i61. PubMed ID: 26069821 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]